BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 17569169)

  • 1. Drug profile: telbivudine (Tyzeka).
    Pham PA; Thio C
    Hopkins HIV Rep; 2007 Jan; 19(1):7, 10. PubMed ID: 17569169
    [No Abstract]   [Full Text] [Related]  

  • 2. Telbivudine (Tyzeka) for chronic Hepatitis B.
    Med Lett Drugs Ther; 2007 Jan; 49(1253):11-2. PubMed ID: 17261968
    [No Abstract]   [Full Text] [Related]  

  • 3. A review of telbivudine for the management of chronic hepatitis B virus infection.
    Lui YY; Chan HL
    Expert Opin Drug Metab Toxicol; 2008 Oct; 4(10):1351-61. PubMed ID: 18798704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of chronic hepatitis B: focus on telbivudine.
    Lui YY; Chan HL
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):259-68. PubMed ID: 19344240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety evaluation of telbivudine.
    But DY; Yuen MF; Fung J; Lai CL
    Expert Opin Drug Saf; 2010 Sep; 9(5):821-9. PubMed ID: 20662545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of chronic hepatitis B with telbivudine: wise hepatologists needed in hepatitis B endemic countries where treatment options are limited.
    Yurdaydin C; Akarca US
    Liver Int; 2011 May; 31(5):589-91. PubMed ID: 21457431
    [No Abstract]   [Full Text] [Related]  

  • 7. [Telbivudine in the treatment of the chronic B hepatitis].
    Butí MA
    Gastroenterol Hepatol; 2008 Apr; 31(4):258-63. PubMed ID: 18405491
    [No Abstract]   [Full Text] [Related]  

  • 8. Telbivudine: a novel nucleoside analog for chronic hepatitis B.
    Kim JW; Park SH; Louie SG
    Ann Pharmacother; 2006 Mar; 40(3):472-8. PubMed ID: 16507625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of telbivudine following oral administration of escalating single and multiple doses in patients with chronic hepatitis B virus infection: pharmacodynamic implications.
    Zhou XJ; Lim SG; Lloyd DM; Chao GC; Brown NA; Lai CL
    Antimicrob Agents Chemother; 2006 Mar; 50(3):874-9. PubMed ID: 16495245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Summaries for patients. Antiviral therapy for chronic hepatitis B.
    Ann Intern Med; 2007 Dec; 147(11):I16. PubMed ID: 17909200
    [No Abstract]   [Full Text] [Related]  

  • 11. Telbivudine: a new option for the treatment of chronic hepatitis B.
    Ruiz-Sancho A; Sheldon J; Soriano V
    Expert Opin Biol Ther; 2007 May; 7(5):751-61. PubMed ID: 17477811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telbivudine versus lamivudine in patients with chronic hepatitis B.
    Tillmann HL; McHutchison JG
    N Engl J Med; 2008 Apr; 358(14):1517; author reply 1517-8. PubMed ID: 18385505
    [No Abstract]   [Full Text] [Related]  

  • 13. Telbivudine: rhabdomyolysis and neuropathy.
    Prescrire Int; 2010 Aug; 19(108):171. PubMed ID: 20941856
    [No Abstract]   [Full Text] [Related]  

  • 14. [Telbivudine in the management of HIV/HBV coinfection. Treating hepatitis B without HIV trouble].
    MMW Fortschr Med; 2009 Apr; 151(18):62-3. PubMed ID: 19769080
    [No Abstract]   [Full Text] [Related]  

  • 15. [Efficacy and safety of telbivudine in pregnant chronic hepatitis B patients].
    Zhou YJ; Zheng JL; Pan HJ; Jiang S
    Zhonghua Gan Zang Bing Za Zhi; 2011 Nov; 19(11):861-2. PubMed ID: 22553840
    [No Abstract]   [Full Text] [Related]  

  • 16. Telbivudine: a new treatment for chronic hepatitis B.
    Amarapurkar DN
    World J Gastroenterol; 2007 Dec; 13(46):6150-5. PubMed ID: 18069753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New treatment of chronic hepatitis B].
    Andersen ES; Weis NM
    Ugeskr Laeger; 2008 Nov; 170(48):3937-9. PubMed ID: 19087730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telbivudine: an effective anti-HBV drug for chronic hepatitis B patients with early on-treatment responses.
    Hann HW
    Expert Opin Pharmacother; 2010 Sep; 11(13):2243-9. PubMed ID: 20698726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telbivudine versus lamivudine in patients with chronic hepatitis B.
    Lai CL; Gane E; Liaw YF; Hsu CW; Thongsawat S; Wang Y; Chen Y; Heathcote EJ; Rasenack J; Bzowej N; Naoumov NV; Di Bisceglie AM; Zeuzem S; Moon YM; Goodman Z; Chao G; Constance BF; Brown NA;
    N Engl J Med; 2007 Dec; 357(25):2576-88. PubMed ID: 18094378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 24-week, parallel-group, open-label, randomized clinical trial comparing the early antiviral efficacy of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive chronic hepatitis B virus infection in adult Chinese patients.
    Zheng MH; Shi KQ; Dai ZJ; Ye C; Chen YP
    Clin Ther; 2010 Apr; 32(4):649-58. PubMed ID: 20435234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.